Bristol Myers Squibb rose Thursday on the back of better-than-expected fourth-quarter earnings but most encouraging was an upbeat outlook from the drugmaker. Bristol Myers reported adjusted earnings of $1.26 a share, topping analysts’ consensus of $1.23. For 2026, Bristol Myers sees adjusted earnings in the range of $6.05 to $6.35 a share, above analysts’ forecasts for $6.02.